An international survey to inform priorities for new guidelines on von Willebrand disease
Open Access
- 26 November 2019
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 26 (1), 106-116
- https://doi.org/10.1111/hae.13881
Abstract
Introduction von Willebrand disease (VWD) is an inherited bleeding disorder caused by a quantitative or qualitative dysfunction of von Willebrand factor. Clinicians, patients and other stakeholders have many questions about the diagnosis and management of the disease. Aim To identify topics of highest importance to stakeholders that could be addressed by guidelines to be developed by the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF) and the World Federation of Hemophilia (WFH). Methods A survey to determine and prioritize topics to be addressed in the collaborative development of guidelines for VWD was distributed to international stakeholders including patients, caregivers and healthcare providers (HCPs). Representatives of the four organizations coordinated the distribution strategy. The survey focused on both diagnosis and management of VWD, soliciting 7‐point Likert‐scale responses and open‐ended comments, in English, French and Spanish. We conducted descriptive analysis with comparison of results by stakeholder type, gender and countries' income classification for the rating questions and qualitative conventional content data analysis for the open‐ended responses. Results A total of 601 participants responded to the survey (49% patients/caregivers and 51% healthcare providers). The highest priority topics identified were diagnostic criteria/classification, bleeding assessment tools and treatment options for women and surgical patients. In contrast, screening for anaemia and differentiating plasma‐derived therapy versus recombinant therapies received lower ratings. Conclusion This survey highlighted areas of importance to a diverse representation of stakeholders in the diagnosis and management of VWD, providing a framework for future guideline development and implementation.Keywords
Funding Information
- American Society of Hematology
This publication has 33 references indexed in Scilit:
- Patients' needs in hematology: whose perspectives?Haematologica, 2013
- Quality of Life in hematology: European Hematology Association theme of the year ... and years to comeHaematologica, 2012
- GRADE guidelines 6. Rating the quality of evidence—imprecisionJournal of Clinical Epidemiology, 2011
- von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding DisorderSeminars in Thrombosis and Hemostasis, 2011
- Reconsidering Patient Participation in Guideline DevelopmentHealth Care Analysis, 2008
- How do you treat bleeding disorders with desmopressin?Published by Oxford University Press (OUP) ,2007
- Three Approaches to Qualitative Content AnalysisQualitative Health Research, 2005
- Whatever happened to qualitative description?Research in Nursing & Health, 2000
- Qualitative Research: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services researchBMJ, 1995
- Prevalence of von Willebrand disease in children: A multiethnic studyThe Journal of Pediatrics, 1993